Flexibility in Phase I Study Timing

Combined Phase I protocols can accelerate access to DDI, QT assessment, food, age, or gender affect, as well as cognitive or dependence data. With earlier access to this information, you have the power to make more informed drug development decisions, and possibly obtain a waiver for certain later-phase studies. We can help you achieve the earliest, most complete understanding of your developmental product.

In this issue of The Altascientist we explain how COMBINED PROTOCOLS can help you, including two illustrative scenarios.



Field will not be visible to web visitor

Copyright 2022 Industry Dive | Privacy Policy | Terms of Use